Results 141 to 150 of about 40,205 (316)

Pamplona

open access: yes, 2011
Panel presentado en Mayo de 2011 para el Proyecto de investigación "La práctica del diseño urbano en las capitales españolas medias (1950-2010)"
openaire   +1 more source

Impact and Effectiveness of COVID‐19 mRNA Vaccination Against COVID‐19 Hospitalisation in Paediatrics: A Cohort Study Using Two Linked Data Sources in Spain

open access: yesPharmacoepidemiology and Drug Safety, Volume 34, Issue 11, November 2025.
ABSTRACT Purpose Despite Spain's > 2 million COVID‐19 paediatric cases before 2024, few required hospitalisations (8900). We aimed to estimate the effectiveness of two‐dose COVID‐19 vaccinations against hospitalisation ‘with’ and ‘for’ COVID‐19 in paediatrics.
Belén Castillo‐Cano   +15 more
wiley   +1 more source

Impact of Hiatus Hernia and Reflux on Bolus Transport Through the Esophagus and the Esophagogastric Junction and in Relation to Dysphagia

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 11, November 2025.
Hiatus hernia alters esophageal anatomy, generating mechanical resistance in the mid‐distal esophagus that impairs bolus transport to the stomach. These findings are also observed in patients with reflux and are associated with dysphagia symptoms. ABSTRACT Background Dysphagia and reflux are frequently experienced by individuals with hiatus hernia (HH),
Fermín Estremera‐Arévalo   +3 more
wiley   +1 more source

ARTIGAS, M., Ciencia y Religión. Conceptos fundamentales

open access: yesPensamiento. Revista de Investigación e Información Filosófica, 2015
(EUNSA, Pamplona, 2007). 422 pp. ISBN: 978-84-313-2490-2.
L. Sequeiros
doaj  

Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double‐blind, placebo‐controlled phase 2 study

open access: yesAlzheimer's &Dementia, Volume 21, Issue 10, October 2025.
Abstract INTRODUCTION ABvac40 is an investigational active immunotherapy (vaccine) targeting Aβ40. This study assessed the safety and immunogenicity of ABvac40 in patients with amnestic mild cognitive impairment or very mild Alzheimer's disease. METHODS AB1601 was a multicenter, randomized, double‐blind, placebo‐controlled phase 2 study.
María Pascual‐Lucas   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy